Oscar Health insider Kushner shifts Class A, B shares
Oscar Health, Inc. (OSCR) reported that on September 18, 2026, entities affiliated with director, Co-Founder and Vice Chairman, and ten percent owner Joshua Kushner reallocated Oscar’s dual-class shares among various Thrive Capital funds.
Rhea-AI Filing Summary
Oscar Health, Inc. (OSCR) reported that on September 18, 2026, entities affiliated with director, Co-Founder and Vice Chairman, and ten percent owner Joshua Kushner reallocated Oscar’s dual-class shares among various Thrive Capital funds. Thrive Capital Partners II, III and Claremount TW exchanged specified amounts of Class B Common Stock for equal amounts of Class A Common Stock held by Thrive Capital Partners VII Growth and Claremount VII, and certain funds then made pro rata, no-consideration distributions of Class A shares to their limited partners and general partners under Rule 16a-9(a) and Rule 16a-13. Class B Common Stock is convertible into Class A Common Stock on a one-to-one basis and will mandatorily convert after a set period and upon certain events, and Kushner, as sole managing member of the Thrive general partners, disclaims beneficial ownership except to the extent of his pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Other | Class B Common Stock F5, F1, F2, F3 | 1,323,589 | $0.00 | $0.00 |
| Other | Class B Common Stock F5, F1, F2, F3 | 4,855,810 | $0.00 | $0.00 |
| Other | Class B Common Stock F5, F1, F2, F3 | 164,218 | $0.00 | $0.00 |
| Other | Class B Common Stock F5, F1, F2, F3 | 6,268,097 | $0.00 | $0.00 |
| Other | Class B Common Stock F5, F1, F2, F3 | 75,520 | $0.00 | $0.00 |
| Other | Class A Common Stock F1, F2, F3 | 6,268,097 | $0.00 | $0.00 |
| Other | Class A Common Stock F1, F2, F3 | 75,520 | $0.00 | $0.00 |
| Other | Class A Common Stock F1, F2, F3 | 1,323,589 | $0.00 | $0.00 |
| Other | Class A Common Stock F1, F2, F3 | 4,855,810 | $0.00 | $0.00 |
| Other | Class A Common Stock F1, F2, F3 | 164,218 | $0.00 | $0.00 |
| Other | Class A Common Stock F4, F2, F3 | 1,323,589 | $0.00 | $0.00 |
| Other | Class A Common Stock F4, F2, F3 | 4,855,810 | $0.00 | $0.00 |
| Other | Class A Common Stock F4, F2, F3 | 164,218 | $0.00 | $0.00 |
| holding | Class B Common Stock F5, F2, F3 | -- | -- | -- |
| holding | Class B Common Stock F5, F2, F3 | -- | -- | -- |
| holding | Class B Common Stock F5, F2, F3 | -- | -- | -- |
| holding | Class B Common Stock F5, F2, F3 | -- | -- | -- |
Footnotes (5)
- F1. On September 18, 2026, (i) Thrive Capital Partners II, L.P. ("Thrive II") transferred 1,307,831 and 15,758 shares of Class B Common Stock to Thrive Capital Partners VII Growth, L.P. ("Thrive VII Growth") and Claremount VII Associates, L.P. ("Claremount VII"), respectively, in exchange for 1,307,831 and 15,758 shares of Class A Common Stock held by Thrive VII Growth and Claremount VII, respectively; (ii) Thrive Capital Partners III, L.P. ("Thrive III") transferred 4,798,003 and 57,807 shares of Class B Common Stock to Thrive VII Growth and Claremount VII, respectively, in exchange for 4,798,003 and 57,807 shares of Class A Common Stock held by Thrive VII Growth and Claremount VII, respectively; (iii) Claremount TW, L.P. ("Claremount TW") transferred 162,263 and 1,955 shares of Class B Common Stock to Thrive VII Growth and Claremount VII, respectively, in exchange for 162,263 and 1,955 shares of Class A Common Stock held by Thrive VII Growth and Claremount VII, respectively.
- F2. Thrive Partners II GP, LLC is the general partner of Thrive II; Thrive Partners III GP, LLC is the general partner of each of Thrive III and Claremount TW; Thrive Partners V GP, LLC is the general partner of each of Thrive Capital Partners V, L.P. ("Thrive V") and Claremount V Associates, L.P. ("Claremount V"); Thrive Partners VI GP, LLC is the general partner of each of Thrive Capital Partners VI Growth, L.P. ("Thrive VI Growth") and Claremount VI Associates, L.P. ("Claremount VI"); Thrive Partners VII Growth GP, LLC is the general partner of Thrive VII Growth; and Thrive Partners VII GP, LLC is the general partner of Claremount VII (together with Thrive II, Thrive III, Claremount TW, Thrive V, Claremount V, Thrive VI Growth, Claremount VI, Thrive VII Growth, the "Thrive Capital Funds").
- F3. (continued from footnote 2) Thrive Partners II GP, LLC, Thrive Partners III GP, LLC, Thrive Partners V GP, LLC, Thrive Partners VI GP, LLC, Thrive Partners VII Growth GP, LLC and Thrive Partners VII GP, LLC are collectively referred to as the "Thrive General Partners." Joshua Kushner is the sole managing member of each of the Thrive General Partners and, in his capacity as managing member, has voting and investment power over the shares held by each of the Thrive Capital Funds. Each of the foregoing entities and Mr. Kushner disclaims beneficial ownership of the shares held of record by the Thrive Capital Funds, except to the extent of its or his pecuniary interest therein.
- F4. On September 18, 2026, (i) Thrive II distributed to its limited partners and sole general partner, pro rata and without consideration, 1,323,589 shares of Class A Common Stock; (ii) Thrive III distributed to its limited partners and sole general partner, pro rata and without consideration, 4,855,810 shares of Class A Common Stock; and (iii) Claremount TW distributed to its limited partners and sole general partner, pro rata and without consideration, 164,218 shares of Class A Common Stock. Each of Thrive Partners II GP, LLC and Thrive Partners III GP, LLC, in turn, distributed to their members, pro rata and without consideration, the shares of Class A Common Stock received in the foregoing distributions. Such distributions were made in accordance with the exemptions afforded by Rule 16a-9(a) and Rule 16a-13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act").
- F5. The Class B Common Stock is convertible at any time at the option of the holder into Class A Common Stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A Common Stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation.
Key Figures
Key Terms
Class B Common Stock financial
pro rata financial
Rule 16a-9(a) regulatory
Rule 16a-13 regulatory
pecuniary interest financial
voting and investment power financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Oscar Health (OSCR) disclose about Joshua Kushner’s role in this Form 4?
What are the conversion terms of Oscar Health’s Class B Common Stock in this filing?
Were the reported OSCR transactions made under a Rule 10b5-1 trading plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.